🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Xuewei Wu

Ningbo University

ORCID: 0000-0003-1722-2278

Also affiliated with Roche (China), Tisch Hospital, Ningbo College of Health Sciences, Icahn School of Medicine at Mount Sinai

Biochemistry, Genetics and Molecular BiologyComputer Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “AKT Degradation Selectively Inhibits the Growth of PI3K/PTEN Pathway–Mutant Cancers with Wild-Type KRAS and BRAF by Destabilizing Aurora Kinase B”.

AKT Degradation Selectively Inhibits the Growth of PI3K/PTEN Pathway–Mutant Cancers with Wild-Type KRAS and BRAF by Destabilizing Aurora Kinase B

Cancer Discovery(2021)10.1158/2159-8290.cd-20-0815
N/A
0.631DataRank · unranked
66 citations

Xufen Yu, Tiphaine Martin, Ankita Bansal, Kakit Cheung, Abigail Lubin +15 more

A local tumor microenvironment acquired super-enhancer induces an oncogenic driver in colorectal carcinoma

Nature Communications(2022)10.1038/s41467-022-33377-8
N/A
0.581DataRank · unranked
47 citations

Jia Xu, Tiphaine Martin, Alexis L. Zachem, John Cijiang He, Sait Öztürk +22 more

Distinct CDK6 complexes determine tumor cell response to CDK4/6 inhibitors and degraders

Nature Cancer(2021)10.1038/s43018-021-00174-z
N/A
0DataRank · unranked
73 citations

Xiaobao Yang, Yan Xiong, Ruitong Li, Takahiro Ito, Tamer A. Ahmed +14 more

Data from Exploiting Allosteric Properties of RAF and MEK Inhibitors to Target Therapy-Resistant Tumors Driven by Oncogenic BRAF Signaling

(2023)10.1158/2159-8290.c.6549364
N/A
0DataRank · unranked
1 citations

Tamer A. Ahmed, Maxwell R. Tucker, Peter M.U. Ung, Min Xiao, Zoi Karoulia +12 more

Resistance mechanisms and therapeutic strategies of CDK4 and CDK6 kinase targeting in cancer

Nature Cancer(2025)10.1038/s43018-024-00893-z
N/A
0DataRank · unranked
46 citations

Xuewei Wu, Christos Adamopoulos, Evripidis Gavathiotis, Poulikos I. Poulikakos, James J. Asciolla

A local tumor microenvironment acquired super-enhancer induces an oncogenic driver for efficient growth under oxidative conditions in colorectal carcinoma

Research Square(2021)10.21203/rs.3.rs-799320/v1
N/A
0DataRank · unranked
0 citations

Jia Xu, Tiphaine Martin, Sait Öztürk, Alexis L. Zachem, John Cijiang He +21 more

Exploiting Allosteric Properties of RAF and MEK Inhibitors to Target Therapy-Resistant Tumors Driven by Oncogenic BRAF Signaling

Cancer Discovery(2021)10.1158/2159-8290.cd-20-1351
N/A
0DataRank · unranked
65 citations

Tamer A. Ahmed, Maxwell R. Tucker, Peter M.U. Ung, Min Xiao, Zoi Karoulia +12 more